News Releases
This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
-
01 03 2020 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the 38th Annual J. P. Morgan Healthcare...
-
12 09 2019 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today the pricing of a public offering of $800 million aggregate principal...
-
12 02 2019 Quest Diagnostics Acquires the Clinical Laboratory Services of Boston Clinical Laboratories in Massachusetts SECAUCUS, N.J. -- December 2, 2019 — Quest Diagnostics (NYSE:DGX), the world’s...
-
11 20 2019 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.53 per share,...
-
11 14 2019 Other Company Research Demonstrates the Value of Diagnostic Insights in Early Cardiovascular Disease Detection in Clinical and Workplace SettingsA laboratory test that evaluates high-density lipoprotein (HDL) cholesterol function provides unique and novel information for assessing cardiovascular disease risk, according to data presented...
-
11 05 2019 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has achieved Gold status in the American Heart Association's 2019 Workplace...
-
10 22 2019 - Third quarter revenues of $1.96 billion, up 3.5% from 2018Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the third quarter ended September 30, 2019. "We...
-
10 16 2019 First-of-its-kind study shows nearly three in four physicians trust their patients to take controlled substances as prescribed, yet half of all patient test results show misuse of these drugsMost primary care physicians (62%) fear the opioid drug crisis will be traded for a new prescription drug crisis and nearly three quarters (72%) worry that chronic pain patients will turn to...
-
10 04 2019 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report third quarter 2019 results on Tuesday, October 22, 2019,...
-
09 19 2019 Quest Diagnostics Recognized for Offering One of the Nation's Best Workforce Health and Well-being InitiativesQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has received the 2019 Best Employers: Excellence in Health & Well-Being...